Cancer of the pancreas
Information
- Disease name
- Cancer of the pancreas
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02905578 | Active, not recruiting | Phase 2 | A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) | November 28, 2018 | December 31, 2025 |
| NCT01838317 | Completed | Phase 2 | A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas | May 2013 | September 20, 2017 |
| NCT02311361 | Completed | Phase 1/Phase 2 | Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer | March 25, 2015 | December 31, 2020 |
| NCT02681796 | Completed | Phase 1 | Epidural Analgesia Use in Pancreatic Resections | June 7, 2016 | February 7, 2020 |
| NCT04542291 | Completed | Phase 1 | Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition | February 25, 2021 | January 19, 2022 |
| NCT02830620 | Completed | N/A | Study at the Man of the Profile of Chimiokines in the Anorexia Bound to the Cancerous Cachexy | August 1, 2012 | December 24, 2019 |
| NCT01446458 | Completed | Phase 1 | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | November 2011 | March 2015 |
| NCT03883919 | Completed | Phase 1 | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy | July 11, 2019 | July 2, 2022 |
| NCT05975593 | Recruiting | MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | December 19, 2023 | December 31, 2032 | |
| NCT05111353 | Recruiting | Phase 1 | Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery | December 15, 2022 | December 31, 2027 |
| NCT03323944 | Recruiting | Phase 1 | CAR T Cell Immunotherapy for Pancreatic Cancer | September 15, 2017 | September 2024 |
| NCT05252390 | Recruiting | Phase 1/Phase 2 | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors | March 29, 2022 | November 2026 |
| NCT04331041 | Recruiting | Phase 2 | Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma | August 24, 2021 | December 31, 2026 |
| NCT02950025 | Terminated | Phase 2 | Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies | January 19, 2017 | March 19, 2018 |
| NCT01231347 | Terminated | Phase 3 | QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | April 2011 | December 2012 |
| NCT01313416 | Terminated | Phase 2 | Gemcitabine and CT-011 for Resected Pancreatic Cancer | September 2012 | January 2017 |
| NCT02352831 | Terminated | Phase 1/Phase 2 | Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma | August 31, 2015 | October 19, 2018 |
| NCT02608229 | Terminated | Phase 1 | BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer | June 6, 2016 | May 21, 2020 |
| NCT02669914 | Terminated | Phase 2 | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors | September 12, 2016 | January 11, 2018 |
| NCT00613730 | Terminated | Phase 2 | Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint | January 2007 | April 2009 |
| NCT03122106 | Terminated | Phase 1 | Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy | January 5, 2018 | August 13, 2022 |
| NCT03956056 | Terminated | Phase 1 | Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy | February 13, 2020 | July 6, 2023 |
| NCT04536077 | Terminated | Phase 2 | Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients | August 13, 2021 | November 21, 2023 |
| NCT03821025 | Unknown status | N/A | Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction | January 1, 2019 | December 31, 2021 |
| NCT04123574 | Withdrawn | Early Phase 1 | A Pilot Study of BXCL701 in Patients With Pancreatic Cancer | October 15, 2019 | December 6, 2021 |